SEARCH

SEARCH BY CITATION

References

  • 1
    Solez K, Colvin RB, Racusen LC et al. Banff'05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007; 7: 518526.
  • 2
    Fahim T, Bohmig GA, Exner M et al. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7: 385393.
  • 3
    Lerut E, Naesens M, Kuypers DR, Vanrenterghem Y, Van Damme B. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplant 2007; 83: 14161422.
  • 4
    Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria —an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708714.
  • 5
    Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ. C4d staining of renal allograft biopsies: A comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568576.
  • 6
    Nadasdy GM, Bott C, Cowden D, Pelletier R, Ferguson R, Nadasdy T. Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Human Pathol 2005; 36: 11781185.
  • 7
    Mengel M, Bogers J, Bosmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005; 5: 10501056.
  • 8
    Magil AB, Tinckam KJ. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant 2006; 21: 13821388.
  • 9
    Lorenz M, Regele H, Schillinger M et al. Risk factors for capillary C4d deposition in kidney allografts: Evaluation of a large study cohort. Transplant 2004; 78: 447452.
  • 10
    Poduval RD, Kadambi PV, Josephson MA et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplant 2005; 79: 228235.
  • 11
    Haas M, Rahman MH, Racusen LC et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant 2006; 6: 18291840.
  • 12
    Fidler ME, Gloor JM, Lager DJ et al. Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant 2004; 4: 101107.
  • 13
    Dickenmann M, Steiger J, Descoeudres B, Mihatsch M, Nickeleit V. The fate of C4d positive kidney allografts lacking histological signs of acute rejection. Clin Nephrol 2006; 65: 173179.
  • 14
    Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006; 6: 20062012.
  • 15
    Mengel M, Chapman JR, Cosio FG et al. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis. Am J Transplant 2007; 7: 512517.
  • 16
    Colvin RB. Eye of the needle. Am J Transplant 2007; 7: 267268.
  • 17
    Karpinski J, Lajoie G, Cattran D et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplant 1999; 67: 11621167.
  • 18
    Bosmans JL, Woestenburg A, Ysebaert DK et al. Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts. Transplant 2000; 69: 23882394.
  • 19
    Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356365.
  • 20
    Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 24642472.
  • 21
    Moreso F, Ibernon M, Goma M et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747752.
  • 22
    Shishido S, Asanuma H, Nakai H et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 10461052.
  • 23
    Einecke G, Broderick G, Sis B, Halloran PF. Early loss of renal transcripts in kidney allografts: relationship to the development of histologic lesions and alloimmune effector mechanisms. Am J Transplant 2007; 7: 11211130.
  • 24
    Famulski KS, Einecke G, Reeve J et al. Changes in the transcriptome in allograft rejection: IFN-g induced transcripts in mouse kidney allografts. Am J Transplant 2006; 6: 13421354.
  • 25
    Haas M, Montgomery RA, Segev DL et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576585.
  • 26
    Seron D, Moreso F. Protocol biopsies in renal transplantation: Prognostic value of structural monitoring. Kidney Int 2007; 72: 690697.
  • 27
    Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006; 6: 20062012.
  • 28
    Hoffmann SC, Hale DA, Kleiner DE et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573581.
  • 29
    Sis B, Famulski K, Hidalo L, Halloran PF. Alloantibody induces c4 deposition and expression of Ifng-dependent transcripts in renal allografts in mice. Am J Transplant 2007; 7: 497.
  • 30
    Baldwin WM, III, Kasper EK, Zachary AA, Wasowska BA, Rodriguez ER. Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant 2004; 4: 311318.
  • 31
    Sis B, Kaplan B, Halloran PF. Histologic findings from positive crossmatch or ABO-incompatible renal allografts: Accommodation or chronic allograft injury? Am J Transplant 2006; 6: 17531754.
  • 32
    Jabs WJ, Sedlmeyer A, Ramassar V et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003; 3: 15011509.
  • 33
    Halloran PF, Urmson J, Ramassar V et al. Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or granzymes A and B. Am J Transplant 2004; 4: 705712.
  • 34
    Einecke G, Fairhead T, Hidalgo LG et al. Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B. Am J Transplant 2006; 6: 21092120.
  • 35
    Mueller TF, Einecke G, Reeve J et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 27122722.
  • 36
    Sis B, Hidalgo L, Reeve J, Mueller T, Halloran PF. Endothelial cell-associated transcripts are selectively increased in antibody-mediated rejection in human renal allografts, and correlate with pathologic features. Am J Transplant 2007; 7: 209.
  • 37
    Ishii Y, Sawada T, Kubota K, Fuchinoue S, Teraoka S, Shimizu A. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 2005; 67: 321332.
  • 38
    Bach FH, Turman MA, Vercellotti GM, Platt JL, Dalmasso AP. Accommodation—A working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991; 23: 205207.
  • 39
    Furness PN, Taub N, Assmann KJ et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805810.
  • 40
    Morozumi K, Takeda A, Uchida K, Mihatsch MJ. Cyclosporine nephrotoxicity: How does it affect renal allograft function and transplant morphology? Transplant Proc 2004; 36: 251S256S.
  • 41
    Sis B, Dadras F, Khoshjou F, Cockfield S, Mihatsch MJ, Solez K. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant 2006; 6: 14441450.
  • 42
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.